LON:BVXP Bioventix (BVXP) Share Price, News & Analysis GBX 2,408 -92.00 (-3.68%) As of 11:43 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About Bioventix Stock (LON:BVXP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Bioventix alerts:Sign Up Key Stats Today's Range 2,400▼ 2,45050-Day Range 2,408▼ 3,02052-Week Range 2,200▼ 4,490Volume8,988 shsAverage Volume7,324 shsMarket Capitalization£126.09 millionP/E Ratio15.57Dividend Yield6.56%Price TargetN/AConsensus RatingN/A Company Overview Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom. Read More Receive BVXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter. Email Address BVXP Stock News HeadlinesDo Its Financials Have Any Role To Play In Driving Bioventix PLC's (LON:BVXP) Stock Up Recently?June 1, 2025 | finance.yahoo.comShareholders in Bioventix (LON:BVXP) are in the red if they invested a year agoMay 6, 2025 | finance.yahoo.comHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold … and reveals a little-known way to get ahead of this bull market.August 8 at 2:00 AM | Weiss Ratings (Ad)5 AIM stocks to consider buying for the long termApril 24, 2025 | msn.com3 UK Dividend Stocks Offering Yields Up To 7.2%April 8, 2025 | finance.yahoo.com3 top AIM stocks to consider buying before they recoverMarch 19, 2025 | uk.finance.yahoo.comWith 62% ownership, Bioventix PLC (LON:BVXP) boasts of strong institutional backingFebruary 9, 2025 | finance.yahoo.comWill the stock market rise in 2025, and how high could it go?December 14, 2024 | msn.comSee More Headlines BVXP Stock Analysis - Frequently Asked Questions How have BVXP shares performed this year? Bioventix's stock was trading at GBX 3,240 at the beginning of the year. Since then, BVXP shares have decreased by 25.7% and is now trading at GBX 2,408. How were Bioventix's earnings last quarter? Bioventix PLC (LON:BVXP) released its earnings results on Monday, March, 31st. The biotechnology company reported $72.27 earnings per share (EPS) for the quarter. Bioventix had a net margin of 59.51% and a trailing twelve-month return on equity of 69.09%. How do I buy shares of Bioventix? Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Bioventix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON). Company Calendar Last Earnings3/31/2025Today8/08/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryCannabis Current SymbolLON:BVXP CIKN/A Webwww.bioventix.com Phone+44-1252-728001FaxN/AEmployees12Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 154.62 Trailing P/E Ratio15.57 Forward P/E Ratio14.48 P/E GrowthN/ANet Income£8.12 million Net Margins59.51% Pretax MarginN/A Return on Equity69.09% Return on Assets54.07% Debt Debt-to-Equity RatioN/A Current Ratio7.42 Quick Ratio5.50 Sales & Book Value Annual Sales£13.65 million Price / Sales9.24 Cash FlowGBX 77.96 per share Price / Cash Flow30.89 Book ValueGBX 229.94 per share Price / Book10.47Miscellaneous Outstanding Shares5,236,318Free FloatN/AMarket Cap£126.09 million OptionableNot Optionable Beta0.35 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (LON:BVXP) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventix PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.